作者
Johan L.K. Van Hove,Marisa W. Friederich,Dana Strode,Roxanne A. Van Hove,Kristen Campbell,Rohit Sharma,Hardik Shah,Jane Estrella,Linda Gabel,Simon Horslen,Rohit Kohli,Mark A. Lovell,Alexander Miethke,Jean P. Molleston,René Romero,James E. Squires,Estella M. Alonso,Maria Oliva‐Hemker,Binita M. Kamath,Kathleen M. Loomes,Philip Rosenthal,Krupa R. Mysore,Laurel Cavallo,Pamela L. Valentino,John C. Magee,Shikha S. Sundaram,Ronald J. Sokol
摘要
Mitochondrial hepatopathies (MHs) are primary mitochondrial genetic disorders that can present as childhood liver disease. No recognized biomarkers discriminate MH from other childhood liver diseases. The protein biomarkers growth differentiation factor 15 (GDF15) and fibroblast growth factor 21 (FGF21) differentiate mitochondrial myopathies from other myopathies. We evaluated these biomarkers to determine if they discriminate MH from other liver diseases in children.
PDF的下载单位、IP信息已删除
(2025-6-4)
大力的灵雁
归尘
橘x
ckeong89
无极微光
互助
干净的琦
pancake
lxaiczn
跳跃的夜柳
殷勤的紫槐
DotBlot
Auston_zhong
luoxiyysgt
GingerF
蓝莓橘子酱
andrele
laber
优秀的流沙
周杰伦
皖公网安备34019202002308
